Talk Bio

Actionable Insights Powered by AI

Subscribe

Innovent Biologics

China Approves Lilly and Innovent’s Mazdutide, Marking New Era for GLP-1 Obesity Drugs

talkbio0Tagged , , , , , , , , ,

Mazdutide; China approval; Innovent Biologics; Eli Lilly; GLP-1 obesity drugs; dual GCG/GLP-1 agonist; NMPA; weight management

Read More